Novo Nordisk (NVO) Stock Price Today & Analysis
NVO
About Novo Nordisk
Novo Nordisk A/S (NYSE: NVO) is a leading global pharmaceutical company from Denmark, a leader in the treatment of diabetes and obesity. With innovative products like Ozempic and Wegovy, NVO's stock price has become a focal point for investors in the global healthcare sector.
FAQ
You can easily purchase Novo Nordisk (NVO) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'NVO' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Novo Nordisk with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
